Profile of patients with type 2 diabetes and glycated haemoglobin ≥ 10% followed in general practice

被引:0
|
作者
Fortin, Frederic [1 ,2 ]
Vorilhon, Philippe [1 ,3 ,4 ]
Laporte, Catherine [1 ,2 ,4 ]
Boirie, Yves [5 ]
Ruivard, Marc [6 ]
Riquelme, Marie [4 ]
Pereira, Bruno [4 ]
Tanguy, Gilles [1 ,3 ]
机构
[1] Univ Clermont Auvergne, Dept Gen Med, UFR Med & Paramed Profess, 28 Pl Henri Dunant R1, F-63000 Clermont Ferrand, France
[2] Univ Clermont Auvergne, Inst Pascal, CNRS, CHU Clermont Ferrand,Clermont Auvergne INP, F-63000 Clermont Ferrand, France
[3] Univ Clermont Auvergne, ACCePPT, F-63000 Clermont Ferrand, France
[4] CHU Clermont Ferrand, Biostat Unit, Clin Res & Innovat Dept, F-63000 Clermont Ferrand, France
[5] CHU Clermont Ferrand, Clin Nutr Serv, F-63000 Clermont Ferrand, France
[6] CHU Clermont Ferrand, Dept Internal Med, F-63000 Clermont Ferrand, France
关键词
diabetes mellitus; general practice; glycated haemoglobin A; patient adherence; quality of life; type; 2; QUALITY-OF-LIFE; GLYCEMIC CONTROL; MEDICATION ADHERENCE; GLUCOSE CONTROL; HEALTH-STATUS; ASSOCIATION; MELLITUS; OUTCOMES; COMPLICATIONS;
D O I
10.1093/fampra/cmab161
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective To determine whether profiles of patients with unbalanced type 2 diabetes (T2DM) and glycated haemoglobin (HbA1c) >= 10% could be identified on the basis of socio-demographic, behavioural, clinical, and biological characteristics. Methods Retrospective, cross-sectional, factorial analysis study of patients with T2DM treated for at least 1 year, with HbA1c >= 10%. Patients were recruited via medical analysis laboratories, France. Patients were followed up in general practice with possible recourse to specialist consultations. Data were collected by means of self-administered questionnaires sent by post. Results A total of 104 patients were included: 69 men and 35 women, with a median age of 66 +/- 12 years, body mass index 30.7 +/- 6.2kg/m(2) and 47% in a vulnerable socio-economic situation. Fifty patients (48%) were followed exclusively by their general practitioners and only 30% had no compliance problems. Creatinuria was measured at least once during the year in 92% of patients, but microalbuminuria was measured in only 20%. Age, socio-economic precariousness, insulin treatment, and follow-up by several health professionals had a negative influence on quality of life (QoL). Two patient profiles were defined by factor analysis: (i) young, rural, smoker, socially isolated, precarious patient with poor compliance and QoL; and (ii) elderly, urban, regular physical activity, in a couple, without precariousness and with satisfactory QoL. Conclusions Analysis of the characteristics of patients with T2DM and glycaemic imbalance reveals profiles that are useful in clinical practice for a personalized approach to treatment and active prevention of diabetes complications.
引用
收藏
页码:432 / 439
页数:8
相关论文
共 50 条
  • [1] ASSOCIATION OF GLYCATED HAEMOGLOBIN WITH LIPID PROFILE IN TYPE 2 DIABETES PATIENTS
    Praveena, Vithpala
    Sreedevi, N. N.
    [J]. JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2018, 7 (04): : 445 - 448
  • [2] RELATIONSHIP BETWEEN GLYCATED HAEMOGLOBIN AND LIPID PROFILE INDICATORS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Chernatska, O. M.
    Fadieieva, H. A.
    Khrapay, H.
    [J]. ATHEROSCLEROSIS, 2021, 331 : E134 - E134
  • [3] Significant correlation of glycated albumin, but not glycated haemoglobin, with arterial stiffening in haemodialysis patients with type 2 diabetes
    Kumeda, Yasuro
    Inaba, Masaaki
    Shoji, Shigeichi
    Ishimura, Eiji
    Inariba, Hiromi
    Yabe, Sachiko
    Okamura, Mikio
    Nishizawa, Yoshiki
    [J]. CLINICAL ENDOCRINOLOGY, 2008, 69 (04) : 556 - 561
  • [4] Metformin decreases glycated albumin to glycated haemoglobin ratio in patients with newly diagnosed type 2 diabetes
    Sumitani, Satoru
    Morita, Shinya
    Deguchi, Reiko
    Hirai, Koichi
    Mukai, Kosuke
    Utsu, Yoshihiko
    Miki, Shunji
    Sato, Bunzo
    Nakamura, Hideji
    Kasayama, Soji
    Koga, Masafumi
    [J]. ANNALS OF CLINICAL BIOCHEMISTRY, 2015, 52 (01) : 76 - 81
  • [5] Metformin adherence in patients with type 2 diabetes and its association with glycated haemoglobin levels
    Chepulis, Lynne
    Mayo, Christopher
    Morison, Brittany
    Keenan, Rawiri
    Lao, Chunhuan
    Paul, Ryan
    Lawrenson, Ross
    [J]. JOURNAL OF PRIMARY HEALTH CARE, 2020, 12 (04) : 318 - 326
  • [6] Associations between usual glycated haemoglobin and cardiovascular disease in patients with type 2 diabetes mellitus: A 10-year diabetes cohort study
    Wan, Eric Y. F.
    Yu, Esther Y. T.
    Chen, Julie Y.
    Wong, Ian C. K.
    Chan, Esther W. Y.
    Lam, Cindy L. K.
    [J]. DIABETES OBESITY & METABOLISM, 2020, 22 (12): : 2325 - 2334
  • [7] Effect of weight reduction on glycated haemoglobin in weight loss trials in patients with type 2 diabetes
    Gummesson, Anders
    Nyman, Elisabeth
    Knutsson, Mikael
    Karpefors, Martin
    [J]. DIABETES OBESITY & METABOLISM, 2017, 19 (09): : 1295 - 1305
  • [8] Genetic determinants of glycated haemoglobin in type 1 diabetes
    Syreeni, A.
    Sandholm, N. K. A.
    Cao, J.
    Toppila, I.
    Forsblom, C.
    Harjutsalo, V.
    Parkkonen, M.
    Valo, E.
    Paterson, A. D.
    Groop, P. -H.
    [J]. DIABETOLOGIA, 2018, 61 : S185 - S185
  • [9] Infections in patients with type 2 diabetes in general practice
    Bartelink, ML
    Hoek, L
    Freriks, JP
    Rutten, GEHM
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 1998, 40 (01) : 15 - 19
  • [10] Effects of splenectomy for hereditary spherocytosis on glycated haemoglobin in a woman with Type 2 diabetes
    McCready, F.
    Cundy, T.
    [J]. DIABETIC MEDICINE, 2009, 26 (05) : 571 - 571